Phenyl chloroformate → Phenyl (4-{4-morpholin-4-yl-6-[(phenylsulfonyl)methyl]pyrimidin-2-yl}phenyl)carbamate

HRID 2353653Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2353653
[N:1]1([C:7]2[CH:12]=[C:11]([CH2:13][S:14]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)(=[O:16])=[O:15])[N:10]=[C:9]([C:23]3[CH:28]=[CH:27][C:26]([NH2:29])=[CH:25][CH:24]=3)[N:8]=2)[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.C(=O)(O)[O-].[Na+].Cl[C:36]([O:38][C:39]1[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=1)=[O:37]>O1CCOCC1>[N:1]1([C:7]2[CH:12]=[C:11]([CH2:13][S:14]([C:17]3[CH:18]=[CH:19][CH:20]=[CH:21][CH:22]=3)(=[O:15])=[O:16])[N:10]=[C:9]([C:23]3[CH:24]=[CH:25][C:26]([NH:29][C:36](=[O:37])[O:38][C:39]4[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=4)=[CH:27][CH:28]=3)[N:8]=2)[CH2:2][CH2:3][O:4][CH2:5][CH2:6]1

Komponenten

5

Versuchsvorschrift

(4-{4-Morpholin-4-yl-6-[(phenylsulfonyl)methyl]pyrimidin-2-yl}phenyl)amine (1 g, 2.44 mmol) was dissolved in dioxane (10 mL). Sodium bicarbonate (307 mg, 3.65 mmol) was added, followed by phenyl chloroformate (0.307 mL, 2.44 mmol) and the reaction stirred at room temperature for 2 hours. The solvent was removed in vacuo, and the resultant oil partitioned between 10 mL DCM and 10 mL water. The organic phase was dried over magnesium sulphate, filtered and concentrated in vacuo. The cream solid obtained was chromatographed on silica, eluting with 0-50% ethyl acetate in DCM, to give the desired material as a white solid (790 mg).

Aufarbeitung

  1. customThe solvent was removed in vacuo
  2. customthe resultant oil partitioned between 10 mL DCM and 10 mL water
  3. dry with materialThe organic phase was dried over magnesium sulphate
  4. filtrationfiltered
  5. concentrationconcentrated in vacuo
  6. customThe cream solid obtained
  7. customwas chromatographed on silica
  8. washeluting with 0-50% ethyl acetate in DCM

Quellen und Nachweise

ORD-Eintrag
ord-e758912cf1144ef8abf21ca3866c1018
Quelldatensatz
uspto-grants-2010_07
Patentnummer
US07750003B2

Notizen zur Reaktion

Wird geladen…